"Dependovirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, which are dependent on a coinfection with helper adenoviruses or herpesviruses for their efficient replication. The type species is Adeno-associated virus 2.
| Descriptor ID |
D000229
|
| MeSH Number(s) |
B04.280.580.650.170
|
| Concept/Terms |
Adeno-Associated Virus- Adeno-Associated Virus
- Virus, Adeno-Associated
- Viruses, Adeno-Associated
- Adeno-Associated Viruses
|
Below are MeSH descriptors whose meaning is more general than "Dependovirus".
Below are MeSH descriptors whose meaning is more specific than "Dependovirus".
This graph shows the total number of publications written about "Dependovirus" by people in this website by year, and whether "Dependovirus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 1999 | 2 | 2 | 4 |
| 2000 | 0 | 1 | 1 |
| 2002 | 3 | 1 | 4 |
| 2004 | 1 | 1 | 2 |
| 2005 | 2 | 1 | 3 |
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 1 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 4 | 5 |
| 2012 | 2 | 4 | 6 |
| 2013 | 6 | 1 | 7 |
| 2014 | 4 | 1 | 5 |
| 2015 | 2 | 5 | 7 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 4 | 5 |
| 2018 | 0 | 4 | 4 |
| 2019 | 4 | 2 | 6 |
| 2020 | 3 | 2 | 5 |
| 2021 | 2 | 4 | 6 |
| 2022 | 1 | 1 | 2 |
| 2023 | 3 | 4 | 7 |
| 2024 | 3 | 1 | 4 |
| 2025 | 3 | 2 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dependovirus" by people in Profiles.
-
Hide-and-Seek genome editing reveals that Gephyrin is required for axo-axonic synapse assembly. Proc Natl Acad Sci U S A. 2025 Aug 12; 122(32):e2500726122.
-
Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life. Nature. 2025 Sep; 645(8082):1020-1028.
-
Rational design of a Lfng-enhancer AAV construct drives specific and efficient gene expression in inner ear supporting cells. Hear Res. 2025 Mar; 458:109203.
-
A comprehensive atlas of AAV tropism in the mouse. Mol Ther. 2025 Mar 05; 33(3):1282-1299.
-
Multiplexed inhibition of immunosuppressive genes with Cas13d for combinatorial cancer immunotherapy. Nat Biotechnol. 2025 Dec; 43(12):2054-2067.
-
In?vivo evolution of env in SHIV-AD8EO-infected rhesus macaques after AAV-vectored delivery of eCD4-Ig. Mol Ther. 2025 Feb 05; 33(2):560-579.
-
Suppression of matrigel-induced choroidal neovascularization by AAV delivery of a novel anti-Scg3 antibody. Gene Ther. 2024 Nov; 31(11-12):587-593.
-
Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector. Transl Vis Sci Technol. 2024 06 03; 13(6):11.
-
A humanized mouse model for adeno-associated viral gene therapy. Nat Commun. 2024 Mar 04; 15(1):1955.
-
Characterization and quantification of adeno-associated virus capsid-loading states by multi-wavelength analytical ultracentrifugation with UltraScan. Nanomedicine (Lond). 2023 09; 18(22):1519-1534.